Pathological responses
Tumor
TUMOR
All patients received neoadjuvant therapy and underwent surgery. Thirty-three (97.1%) patients underwent total gastrectomy plus D2 lymphadenectomy, and 1 (2.9%) underwent proximal gastrectomy with D2 lymphadenectomy. The rate of R0 resection was 100%. Thirty-one (91.2%) patients underwent adjuvant therapy, while 3 did not due to refusal (Tumor shrinkage from baseline is shown in Fig. 